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Background: ZIC1, a vital transcription factor with zinc finger domains, has been implicated in the process of neural
development. We previously showed that ZIC1 may function as a tumour suppressor in gastrointestinal cancers.
However, the molecular mechanism underlying ZIC1 participation in tumour progression remains unknown.
Methods: The role of ZIC1 on cell proliferation and migration was examined. The regulation of sonic hedgehog (Shh),
phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling pathways after ectopic
expression of ZIC1 in gastric cancer cells were evaluated.
Results: Overexpression of ZIC1 contributes to the inhibition of cell proliferation migration and cell-cycle distribution in
gastric cancer. The modulation of G1/S checkpoint by ZIC1 is mainly mediated through the regulation of cyclin-
dependent kinases (p21 Waf1/Cip1, p27 Kip1 and cyclin D1). In addition, ZIC1 can inactivate the level of phospholated Akt
and Erk1/2, and transcriptionally regulate sonic hedgehog (Shh) signaling, thus leading to regulate the expression of
p21 Waf1/Cip1 and cyclin D1. Finally, we have systemically identified ZIC1 downstream targets by cDNA microarray
analysis and revealed that 132 genes are down-regulated and 66 genes are up-regulated after transfection with ZIC1 in
gastric cancer cells. These candidate genes play critical roles in cell proliferation, cell cycle and cell motility.
Conclusions: Overexpression of ZIC1 results in inactivation of Shh, PI3K and MAPK signaling pathways, as well as
regulation of multiple downstream targets which are essential for the development and progression of gastric cancer.
ZIC1 serves as a potential therapeutic target for gastric cancer.
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ZIC1, one of five ZIC family genes, is involved in a var-
iety of developmental processes, including neurogenesis
and myogenesis [1,2]. Recently, ZIC1 has been docu-
mented to participate in the progression of human
tumours including medulloblastoma, endometrial can-
cers, mesenchymal neoplasms and liposarcoma cancers
[3–6]. We have previously shown that ZIC1 gene is sig-
nificantly downregulated in gastric cancer tissues and* Correspondence: wanglj76@hotmail.com
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reproduction in any medium, provided the orcell lines when compared with that of normal gastric tis-
sues. In addition, ZIC1 potentially serves as a tumour
suppressor by inhibiting cell proliferation in gastric and
colorectal cancer cells [7,8]. As an important transcrip-
tion factor, ZIC1 is essential to the regulation of Hedge-
hog signaling (Hh), Bone morphogenetic protein (BMP),
and Notch signaling pathways in neural development
[2,9]. However, little is known about how ZIC1 regulates
signal pathways and their related downstream targets in
cancer progression.
Gastric cancer is the second leading cause of cancer-
related death worldwide [10,11]. Hh signaling is one of the
key oncogenic signaling pathways involved in gastric car-
cinogenesis [12,13]. Sonic hedgehog (Shh), a member ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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be both upregulated in gastric cancer tissues by in situ
hybridization assay and essential for the progression of
gastric cancer [13,15]. Hh signaling pathway is activated
by Shh binding with the Patched (Ptch)- Smoothened
(Smo) membrane-receptor complex [16]. The activation
of Shh promotes gastric cancer cell differentiation and
proliferation. It has been reported that ZIC1 could reduce
the expression of PTCH1 and Shh genes in neural tissue
during forebrain development [17]. In contrast, evidence
has shown that the Shh represses the expression of ZIC1
during neural tube development [18]. Nevertheless, the in-
fluence of ZIC1 on the Hh signaling pathway in gastric
cancer remains unknown.
ZIC1 also regulates numerous targets including cyclin
D1, p27, Wnt1 and Wnt7a during neural development in
xenopus ectodermal explants and mutant mice models
[9,19,20]. We are particularly interested in cell-cycle regu-
lators important for cancer cell proliferation and differen-
tiation. We have previously shown that overexpression of
ZIC1 can alter G1/S transition in gastric cancer cells [8].
Several mechanisms of Cyclin dependent kinases (CDKs)
are involved in the regulation of G1/S checkpoint in
human cancers [21]. During transition from G1 to S
phase, cyclin D which forms active complexes with CDK4
is up-regulated in gastric cancer [22,23]. Loss of cyclin
dependent kinase inhibitors such as p21Waf1/Cip1 and
p27Kip 1 promote CDK2 activity and regulate the G1/S
transition [12,24]. Recent studies have demonstrated that
mutant ZIC1 or force overexpression of ZIC1 regulates
the expression of p27 Kip 1 in mice cerebellar tissues and
liposarcoma cells [3,20]. Interestingly, the Shh signaling
pathway negatively regulates p21 Waf1/Cip1 and cyclin D1
in a GLI1-dependent manner [16,25]. However, whether
ZIC1 can interplay with Shh pathway in the regulation of
cell cycle distributions has not been defined. Elucidation
of this signaling network may provide further insight into
the role of ZIC1 in gastric cancer.
In our present study, we demonstrate that overexpres-
sion of ZIC1 suppresses gastric cancer cell migration
and invasion, as well as alters the cell-cycle distributions.
ZIC1 can transcriptionally downregulate the Shh signal-
ing and suppress the level of phospholated Akt and Erk,
thus leads to the regulation of cell-cycle regulator
kinases p21Waf1/Cip1, p27Kip1 and cyclin D1 in gastric
cancer cells. We also identified multiple important ZIC1
downstream targets in gastric cancer cells by cDNA
microarray analysis.
Results
ZIC1 inhibits proliferation, migration and invasion of
gastric cancer cells
To determine the effect of ZIC1 on cell proliferation, we
performed cell viability analysis by MTS assays in gastriccancer cells. Gastric cancer cell lines (AGS, MKN28,
BGC823 and SGC7901) were transfected with
pCDNA3.1-ZIC1 or pCDNA3.1 empty vector. The
transfection efficiency was confirmed by RT-PCR and
western blot respectively (Figure 1A). Results showed
that the number of viable cells was significantly sup-
pressed by ectopic expression of ZIC1 in a 5-day obser-
vation in BGC823 cells (Figure 1B). The suppression of
cell proliferation by ZIC1 was consistent with our previ-
ous observations in AGS and MKN28 gastric cancer
cells, as well as colon cancer cells [7,8].
In addition, we determined the role of ZIC1 in cell mi-
gration and invasion in gastric cancer. Cell migration and
invasion assays were performed in transwell migration
and Matrigel-coated invasion assay systems, respectively.
We observed that re-expression of ZIC1 significantly sup-
pressed cell migration in AGS, BGC823 and SGC7901
gastric cancer cell lines (p< 0.001) (Figure 1C,D). In
addition, re-expression of ZIC1 displayed a significantly
lower activity of cellular invasion when compared to those
empty vector transfectants in AGS cells (p< 0.05) (Add-
itional file 1: Figure S1). These data suggest that ectopic
expression of ZIC1 suppresses gastric cancer cell migra-
tion and invasion.
ZIC1 alters cell-cycle distributions and regulates the
expression of cyclin-dependent kinases in gastric cancer cells
To further understand the mechanisms underlying the in-
hibition of cell proliferation by overexpression of ZIC1, we
evaluated cell-cycle distributions in gastric cancer cells.
We observed a higher proportion of cells in G1 phase in
AGS (42.74 %) and SGC7901 (54.03 %) cell lines after
overexpression of ZIC1. However, in the cells transfected
with a control vector, the proportion was decreased both
in AGS (32.66 %) and SGC7901 (47.00 %) and the propor-
tion of cells in S phase was relatively increased
(Figure 2A). It is well accepted that p21 (also known as
p21Waf1/Cip1) and p27 (also known as p27KIP1), two main
cyclin-dependent kinase inhibitors, are required for cessa-
tion during the entry to S-phase [26]. The activation of
Cyclin D1, however, is mainly responsible for regulating
the G1-S phase transition [23]. We demonstrated that the
expression level of cyclin D1 protein was reduced while
p21 and p27 were markedly induced in gastric cancer cells
transfected with pCDNA3.1-ZIC1 when compared to
those pCDNA3.1 empty vector transfectants (Figure 2B).
We also evaluated the cell apoptosis distributions in
pCDNA3.1-ZIC1 or pCDNA3.1 vector transfectants in
AGS and MKN28 cells, but no obvious differences of cell
apoptosis were observed (Additional file 2: Figure S2).
Therefore, these results support that overexpression of
ZIC1 alters the cell cycle distributions through regulation
of cyclin-dependent kinases p21, p27 as well as cyclin D1
in gastric cancer cells.
Figure 1 ZIC1 suppresses cell proliferation and migration in gastric cancer. (A) Gastric cancer cell lines (AGS, MKN28, BGC823 and SGC7901)
were stably transfected with pCDNA3.1-ZIC1 or pCDNA3.1 empty vector. The expression levels of ZIC1 mRNA and protein were performed by RT-PCR
(upper diagram) and Western blot (low diagram). GAPDH and β-actin were used as internal controls. (B) The cell viability of gastric cancer cell line
(BGC823) was determined by MTS cell proliferation assay. The asterisk indicates statistical significance (**p< 0. 01). (C) Cell migration was assessed by
modified Boyden transwell chambers assays after incubation for 16 h. Cells that migrated to the bottom of the membrane were stained with DAPI. (D)
The number of visible migratory cells (mean± S.D) was estimated by counting five random high power fields (×400 magnification). These experiments
were performed in triplicate. The representative data are shown. The asterisk indicates statistical significance (***p< 0.001).
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tion of cell-cycle kinases. We evaluated the expression of
main downstream effectors of these two pathways, Erk1/2
and Akt, after stably introducing pCDNA3.1-ZIC1 to
AGS, MKN28, BGC823 and SGC7901 gastric cancer cells
(Figure 1A). We found that the phosphorylation levels of
Erk1/2 and Akt were dramatically suppressed by overex-
pression of ZIC1 in all above cell lines tested (Figure 2C).
These results suggested that the regulation of cell-cylce
distribution by ZIC1 may be mediated through PI3K and
MAPK pathways and their downstream cyclin-dependent
kinases p21, p27 and cyclin D1 in gastric cancer.
ZIC1 suppresses the expression of Sonic hedgehog (Shh)
in gastric cancer cells
Molecular characterization has shown that ZIC1 has zinc-
finger domains and could counteract with GLI1 by bind-
ing to GC-rich sequences [2]. GLI1 is a downstream target
of hedgehog (hh) signaling pathway which is essential to
gastric cancer development and progression [9,27]. Wehypothesized that Hh signaling pathway may be involved
in the ZIC1 regulation of gastric cancer cell-cycle and cell
migration. To address this issue, we examined the expres-
sion of Sonic hedgehog (Shh), a key member of Hh family,
in gastric cancer cells after overexpression of ZIC1. We
found that re-expression of ZIC1 effectively reduces Shh
expression in BGC823 and SGC7901 cell lines by western
blot analysis (Figure 3A). In addition, the RT-PCR analysis
demonstrated that the transcript level of Shh is also sig-
nificantly downregulated in gastric cancer cells transfected
with ZIC1 relative to empty vector transfectants (p< 0.01)
(Figure 3B) .(Additional file 3: Figure S3). Taken together,
our results suggest that ZIC1 may transcriptionally regu-
late the expression of Shh in gastric cancer cells.
Hedgehog (Hh) signaling pathway is involved in the ZIC1
regulation of cell-cycle and cell migration in gastric cancer
cells
To determine the effect of Shh on cell-cycle distributions,
we sought to examine the effects of pharmacologic inhibitor
Figure 2 ZIC1 alters cell-cycle distributions by regulation of p21, p27 and cyclin D1 in gastric cancer cells. (A) Cell cycle distributions
were detected by flow cytometry analysis in AGS and SGC7901 cells after transient transfection with pCDNA3.1-ZIC1 or pCDNA3.1 empty vector
for 24 h. (B) The expression levels of p21, p27 and cyclin D1 were determined by Western blot. β-actin was detected as a loading control.
Densitometry values are expressed as fold change compared with pCDNA3.1 vector control values normalized to 1. (C) The expression levels of
phospholated Akt and Erk1/2, as well as total Akt and Erk1/2 were examined by Western blot.
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Figure 3 ZIC1 inhibits the expression of Sonic hedgehog (Shh).
(A) The expression of Shh protein was analyzed by Western blot in
BGC823 and SGC7901 cells stably transfected with pCDNA3.1-ZIC1 or
pCDNA3.1 empty vector. (B) The expression level of Shh mRNA was
determined by real-time quantitative RT-PCR analysis. The relative
expression level was expressed as fold change (mean± SEM)
compared with pCDNA3.1 empty vector normalized to 1.
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AGS, BGC823 and SGC7901 gastric cancer cell lines were
treated with cyclopamine (10 μM), a steroidal alkaloid that
interacts directly with Smo to inhibit Hh signaling [28], or
DMSO control for 24 h. We observed that the expression
level of p21 was markedly up-regulated, while cyclin D1
down-regulated after tumour cells were treated with
cyclopamine (Figure 4A). Of note, blocking the Shh sig-
naling pathway by administration of cyclopamine does not
affect the expression levels of ZIC1 mRNA in BGC823
and SGC7901 cells by RT-PCR assays (Figure 4B). The ab-
sent or low expression of ZIC1 mRNA in gastric cancer
cells was mainly meditated by promoter DNA methylation
as we described previously [8].
We also evaluated the effects of Shh signaling on gastric
cancer cell migration. As shown in Figure 4 C and D, AGS,
BGC823 and SGC7901 gastric cancer cell lines showed sig-
nificant decrease in cellular migration after administration
with cyclopamine (10 μM) for 24 h (p< 0.01). Collectively,
these results demonstrate that ZICI may modulate the cell-cycle regulators and cell migration through Shh signaling
in gastric cancer cells.
Gene expression profile changes by ectopic expression of
ZIC1
To systematically determine downstream targets of
ZIC1, we conducted an affymatrix oligonucleotide
microarray in MKN28 gastric cancer cells with or with-
out pCDNA3.1-ZIC1. Using a cut-off of >1.5 fold for
statistical significance, a microarray revealed that 132
genes are down-regulated while 66 genes are up-
regulated by exogenous expression of ZIC1 (representa-
tive genes shown in Figure 5A). Many genes have been
reported to play critical roles in cell proliferation, cell
cycle and cell migration according to gene functional
analysis (http://www.genecards.org) (Figure 5B). For in-
stance, two key cell-cycle regulators TP53INPI and
CDKN2B are found to be deregulated in MKN28 cells
tranfected with pCDNA3.1-ZIC1. Our results indicate
that ZIC1 potentially regulates multiple downstream
genes involved in gastric tumorigenesis.
Discussion
Growing evidence has shown that ZIC1 is involved in
the progression of several tumours [3–8]. It appears that
ZIC1 is aberrantly expressed in certain types of cancer
and differentially functions as a tumour suppressor or
oncogenic gene. For instance, ZIC1 expression was
reported to be low or absent in gastrointestinal and lung
cancer cell lines, and was found to suppress gastrointes-
tinal cancer cell proliferation [7,8,29]. In contrast, over-
expression of ZIC1 in liposarcoma was found to
promote cell proliferation and invasion [3]. We and
others have demonstrated that the epigenetic modula-
tions including DNA methylation and histone remodel-
ing, and genetic mutations may contribute to its
differential expression patterns in cancers [3,4,7,8]. It is
becoming clear that as a zinc finger transcription factor,
ZIC1 may modulate multiple downstream genes in
neural tissue, colorectal cancer and liposarcoma cells
[2,3,7,9]. However, little is known about the mechanism
underlying ZIC1 function in the development and pro-
gression of gastric cancer. Underscoring the key path-
ways and downstream targets regulated by ZIC1 may
facilitate our understanding of its roles in tumorigenesis.
Here, we have demonstrated that overexpression of
ZIC1 results in significant inhibition of cell survival and
impairment of cell migration. ZIC1 suppresses the Shh ,
PI3K and MAPK signaling pathways which are critical
for the regulation of cell-cycle distributions and cell mi-
gration in gastric cancer. Moreover, ZIC1 inhibits cell
cycle regulatory kinases, p21, p27 and cyclin D1, thus
leading to G1/S cell cycle transit in gastric cancer cells.
ZIC1 suppresses the Shh signaling pathway which is
Figure 4 Hh signaling pathway is involved in the expression of p21, cyclin D1 and regulation of cell migration. AGS, BGC823 and
SGC7901 gastric cancer cells were treated with cyclopamine (10 μM), a steroidal alkaloid that interacts directly with Smo to inhibit Hh signaling,
or DMSO control for 24 h. (A) The expression levels of p21 and cyclin D1 were determined by western blot in AGS, BGC823 and SGC7901 cells.
(B) The expression level of ZIC1 mRNA was examined through conventional RT-PCR. (C) Cell migration was assessed by modified Boyden
transwell chambers assays. Cells that migrated to the bottom of the membrane were stained with DAPI. (D) The mean number of visible
migratory cells (mean± S.D) was calculated in five random high power fields (×400). The asterisk indicates statistical significance (***p< 0.001).
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cell migration in gastric cancer.
MAPK and PI3K pathways play critical roles in cell
proliferation, differentiation, and progression in a variety
of human cancers [30]. Recently, it was also reported
that the activation of both pathways are essential to in-
duce cell cycle entry [30,31]. During this process, cyclin
dependent kinase inhibitors p21, p27 and cyclin D/E
participate in the regulation of p53 induced cell-cycle ar-
rest [24,32]. The activation of MAPK and its down-
stream kinase-Erk could not only lead to the induction
of cyclin D1 and pass through G1/S checkpoint, but also
the accumulation of p21 that inhibits cyclin E/CDK2
complexes to block S-phase entry [30]. PI3K/Akt path-
way could inactivate the Gsk3-β and FOXO transcrip-
tion factors, thus inhibit cyclin D1 while induce p27 and
p21 in the regulation of cell-cycle entry [31]. We have
shown that re-expression of ZIC1 effectively inactivate
the phosphorylated Akt and Erk1/2 in AGS, MKN28,
BGC823 and SGC7901 gastric cancer cell lines. In this
regard, the CDK1 inhibitor p21 was activated, whilecyclin D1 inactivated, after overexpression of ZIC1 in
gastric cancer cells. Though the results need to be vali-
dated in future studies, our miroarray data have revealed
that other key components of cell cycle kinase regulators
including TP53INPI and CDKN2B, are deregulated with
forced expression of ZIC1 in an individual MKN28 gas-
tric cancer cell line (Figure 5 A and B). Therefore, we
propose that ZIC1 regulates G1/S transit mainly through
PI3K and MAPK pathways and downstream cell-cycle
regulator kinases in gastric cancer cells.
Another major finding in our present study is that
ZIC1 transcriptionally regulates Sonic hedgehog (Shh)
signaling in gastric cancer cells. Aside from its central
role on regulating gastric gland morphogenesis in
human stomach, Shh signaling is also involved in the
pathogenesis of gastric cancer [16,33]. Shh is frequently
activated in advanced gastric adenocarcinomas and asso-
ciated with aggressive tumour behavior [13,15,33]. Previ-
ous studies have shown that Shh signaling promotes the
motility and invasiveness of gastric cancer cells through
TGF-β-ALK5-Smad3 pathway [34]. Shh signaling could
Figure 5 Gene expression profile changes after ectopic expression of ZIC1. (A) The gene expression profiles in pCDNA3.1-ZIC1 or empty
pCDNA3.1 vector stable transfectants were analyzed by cDNA microarray in MKN28 cells. Representative genes are illustrated on the right side of
the heatmap image using a cut-off >1.5 or<−1.5 fold as a significant difference,. (B) Genes involved in cell cycle, cell proliferation and cell
migration according to gene functional analysis (http://www.genecards.org) are presented. Relative fold change is expressed with ratio of
pCDNA3.1-ZIC1 versus pCDNA3.1 control. (C) Systemic understanding of pathways for ZIC1 regulation of signaling and target genes in the
development and progression of gastric cancer.
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Gli-dependent pathway [16,25]. We have observed that
inhibition of Shh signaling by administration with cyclo-
pamine suppresses AGS, BGC823 and SGC7901 gastric
cancer cell migration, and regulates the expression of
p21 and cyclin D1 (Figure 4). These results are consist-
ent with previously reported studies [25,34]. Thus, we
have revealed that ZIC1 plays important roles in gastric
cancer progression by regulation of the Shh signaling
pathway.ZIC1 may regulate target genes in both sequence-
specific and independent manners [9]. ZIC1 could regu-
late the transcriptional expression of targets including
cyclin D1, p27, Wnt1 and Wnt7a, and modulate Notch
and BMP pathways in neural development [2,9]. ZIC1
could counteract GLI by binding to GC-rich sequences,
and suppress the expression of GLI-binding sequence
directed reporter genes [9,35]. We identified several ZIC
potential target genes in gastric cancer cells by micro-
array analysis. These targets are closely related to cell
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association between ZIC and downstream targets might
be a clue for understanding the potential perspective of
ZIC proteins in the progression of gastric cancer.
Conclusions
Summarily, we propose a model that represents the path-
ways through which ZIC1 contributes to gastric cancer
progression (Figure 5C). Overexpression of ZIC1 results
in suppressing Hedgehog (Hh) signaling and its down-
stream targets including p21, p27 and cyclin D1. As a zinc
finger transcription factor, ZIC1 also potentially modulates
the transcriptional expression of target genes by directly
binding to GC-rich sequences [2], thus functioning as a
tumour suppressor by inhibition of cell proliferation, cell
migration and invasion in gastric cancer.
Methods
Cell culture and treatment
The human gastric cancer cell lines (AGS, MKN28,
BGC823 and SGC7901) were obtained from Riken Gene
Bank (Japan) and American Type Culture Collection
(ATCC, Manassas, VA, USA). All cell lines were cultured
in RPMI 1640 medium (Invitrogen, CA, USA) supplemen-
ted with 10 % fetal bovine serum (FBS) and incubated at
5% CO2, 37°C and 95 % humidity. Gastric cancer cell lines
(AGS, BGC823, and SGC7901) were treated with 10 μM
of cyclopamine (Sigma, St Louis, MO, USA) in DMSO for
24 hours. An equivalent concentration of the vehicle
(DMSO) was used as the control.
Cell transfection
AGS, MKN28, BGC823 and SGC7901 cells were cultured
for 24 h in a 6-well plate and transfected with pCDNA
3.1-ZIC1 or pCDNA 3.1 empty vector using Fugene HD
(Roche) according to the manufacturer's instructions.
After 48 h, the transfectants were continuously selected in
RPMI 1640 medium containing G418 (200–400 μg/mL)
(Merck, Germany) for 14 days.
RT-PCR and quantitative real time PCR analysis
Total RNA (1 μg) was extracted using Trizol reagent
(Invitrogen) following manufacturer’s instructions and
reverse transcribed into cDNA with M-MLV RTase cDNA
Synthesis Kit (Takara, Japan). The transcript levels of ZIC1
and Shh were determined by conventional RT-PCR with
TaKaRa Taq polymerase (Takara, Japan) or Quantitative
real-time PCR (qRT-PCR) with the SYBR Green Master
Mix Kit (Takara, Japan) in an ABI 7500 PCR system. Primers
used for ZIC1 were F: 5’-AAACTGGTTAACCACATCCGC
and R: 5’-CTCAAACTCGCACTTGAAGG. Shh were F:
5’-GTAAGGACAAGTTGAACGCTTTG and R: 5’-GATA
TGTGCCTTGGACTCGTAGTA. Glyceraldehyde-3-;phos-
ohate dehydrogenase (GAPDH) was used as an internalcontrol. The transcript levels are expressed as 2-ΔΔCt values
and relative expression fold change is normalized to
GAPDH.
Cell viability assay
Cell viability was detected with a nonradioactive cell
proliferation assay with 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2 H-tetra-
zolium (MTS) reagents (Promega, Madison, USA).
Stable transfected cells were plated in 96-well (2000
cells/well) for 6 h, 24 h, 72 h and 120 h. The absorbance
was measured at 490 nm after 1 h incubation with Cell-
Titer 96 Aqueous One Solution reagent.
Cell-cycle and cell apoptosis analysis
Cell cycle distributions were detected by the flow cytome-
try analysis. Cells transfected with pCDNA3.1-ZIC1 or
pCDNA3.1 empty vector were harvested and washed with
PBS. Cellular DNA was stained with cell cycle staining so-
lution containing propidium iodide (PI) at 4 °C in dark.
Cell cycle was determined using a FACS Calibur and ana-
lyzed with the ModFitLT software (Phoenix, USA).
Cell apoptosis was performed using FITC Annexin V
Apoptosis Detection Kit II (BD Pharmingen) by flow cyto-
metry analysis. Transiently transfected cells were sus-
pended in Annexin V Binding Buffer. Then FITC Annexin
V and PI solutions were added in sequence. After incuba-
tion for 15 min, the stained cells were analyzed by flow
FACScan flow cytometry (Becton Dickinson, USA).
Cell migration and invasion assays
Cell migration was assessed by modified Boyden transwell
chambers assay (Coring, USA). Briefly, cells were cultured
in serum-free medium for 24 h and 5× 104 cells were pla-
ted to the upper chamber in 300 μL medium containing
5 % FBS. After 16 h of incubation, non-migratory cells in
the upper chamber were carefully removed with a cotton
swab. Migrated Cells were stained with DAPI Staining So-
lution. The cell numbers were randomly counted in five
fields (×400 magnification).
Cell invasion was performed in a millipore 24-well
coated with BD Matrigel. After starvation in serum-free
medium for 24 h, 1 × 105 cells were plated to the upper
chamber in 300 μL of medium containing 5 % FBS, while
the lower chamber was filled with 600 μL of culture
medium with 15 % FBS. After having been incubated for
30 h, the membranes were incubated with Cell Stain Solu-
tion (Millorpore, USA). The dye mixture was washed by
Extraction Buffer and transferred to a 96-well for colori-
metric measurement at 560 nm.
Western blot analysis
Total proteins were extracted from cells using radio-
immunoprecipitation assay lysis buffer supplemented with
Zhong et al. BMC Cancer 2012, 12:290 Page 9 of 10
http://www.biomedcentral.com/1471-2407/12/290protease inhibitor. Lysates were resolved on 6-12 % SDS-
PAGE minigels and transferred to PVDF membranes
(Millipore, Bedford, MA). Membranes were blocked in
5 % milk with TBST and incubated in 4°C overnight with
following antibodies: ZIC1 (1:500; Abcam), phospho-Akt
(1:1000; Cell Signaling), Akt (1:500; Abcam), phospho-
Erk1/2 (1:1000; Cell Signaling), Erk1/2 (1:1000; Cell Sig-
naling), p21Waf1/Cip1 (1:1000; Cell Signaling), p27 Kip1
(1:500; Epitomics), cyclin D1 (1:1000; Cell Signaling) and
Shh (1:1000; Cell Signaling). Accordingly, secondary anti-
bodies coupled to horseradish peroxidise (HRP) were
visualized using a chemiluminescence with Las-4000 Im-
aging System (Fujifilm, Japan). The relative densities of
proteins were quantified with Image J. software and nor-
malized to β-actin (1:2500, Multisciences Biotech).
cDNA microarray analysis
Total RNA was isolated from MKN28 cells which stably
transfected with pCDNA3.1-ZIC1 or pCDNA3.1 empty
vector, and was reverse transcribed to cDNA. Labeled
samples were hybridized with Agilent whole human gen-
ome containing more than 41,000 probes (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38924). The
microarray data were analyzed using Agilent Feature Ex-
traction software. We selected a fold change ≥1.5 or
≤−1.5 as a significant difference.
Statistical analysis
Student’s t test was performed to compare two-
independent data, while Chi-square or fisher exact test
was used to analyze categorical variables. A cut-off of
p < 0.05 was applied for statistical significance.
Additional files
Additional file 1: Figure S1. ZIC1 suppresses gastric cancer cell invasion.
A BD Matrigel coated chamber was used to assess cell invasion. 1 × 105
AGS cells stably transfected with pCDNA3.1-ZIC1 or pCDNA3.1 empty
vector were plated to the upper chamber and incubated for 24 h.
Invaded cells were stained with Cell Stain solution, and detected on a
standard microplate reader (560 nm). The relative invaded cells are
expressed as the percentage rate compared with pcDNA3.1 empty vector
transfectants (Bars, ±S.D. ; *p< 0.05).
Additional file 2: Figure S2. ZIC1 does not affect the cell apoptotic
activity in gastric cancer cells. The cell apoptosis rate was determined by
the Annexin V-PI flowcytometry assay after transient transfection with
pCDNA3.1-ZIC1 or pCDNA3.1 empty vector in AGS and MKN28 cells for
24 h. Region LR indicates the percentage of early apoptotic cells, UR
shows late apoptotic cells.
Additional file 3: Figure S3. Overexpression of ZIC1 inhibits the
expression of Shh mRNA. AGS and SGC7901 cells were stably transfected
with pCDNA3.1-ZIC1 or empty vector pCDNA3.1. The expression levels of
ZIC1 and Shh mRNA were performed by RT-PCR. GAPDH was used as an
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